Media Releases
Panel Test for 5 Genetic Diseases
To help breeders make informed decisions, AQHA is now offering a panel test for five genetic diseases, which includes: glycogen branching enzyme deficiency (GBED); heredity equine regional dermal asthenia (HERDA); hyperkalemic periodic paralysis (HYPP); malignant hyperthermia (MH) and polysaccharide storage myopathy (PSSM).
When the test is ordered, AQHA will send a DNA kit, and the owner will mail it to the Veterinary Genetics Laboratory at the University of California-Davis for testing. Once the tests are complete, AQHA will notify the owners and put the results on the horse's record and certificate of registration.
The tests cost $85 for members and $125 for nonmembers. For the panel test in conjunction with the DNA test required for most breeding stock, the cost is $105 for members.
The effects of these genetic diseases are wide-ranging, from mild and manageable to severe and terminal. Check out the AQHA web site for specific information about the genetic diseases in the panel test.
When the test is ordered, AQHA will send a DNA kit, and the owner will mail it to the Veterinary Genetics Laboratory at the University of California-Davis for testing. Once the tests are complete, AQHA will notify the owners and put the results on the horse's record and certificate of registration.
The tests cost $85 for members and $125 for nonmembers. For the panel test in conjunction with the DNA test required for most breeding stock, the cost is $105 for members.
The effects of these genetic diseases are wide-ranging, from mild and manageable to severe and terminal. Check out the AQHA web site for specific information about the genetic diseases in the panel test.
© WI Quarter Horse Association Promoting the American Quarter Horse and its industry by being the preferred state breed association.
